Twist Bioscience: Long-Term 'Buy' On AI Discovery For Biotech
A Seeking Alpha article presents a long-term bullish view of Twist Bioscience, arguing that AI drug discovery, repeat testing, lab data work, and personalized cancer testing could expand customer demand for the company’s services.
Why it matters — The article’s growth case centers on potential opportunities across drug discovery and diagnostics that may interest TWST watchers.